1-4 of 4
Anne Gardiner, BSc
Close
Sort by
Journal Articles

13q Deletion Size Predicts Disease Progression and Response to Treatment in Patients with Chronic Lymphocytic Leukaemia.

Jonathan C Strefford, PhD, Helen Parker, PhD, Anton Parker, BSc, Hazel Robinson, PhD, Tracy Chaplin, MSc, Xiao-He Chen, PhD, David Bunyan, PhD, Anne Gardiner, BSc, Bryan D Young, PhD, David Graham Oscier, MD
Journal: Blood
Blood (2009) 114 (22): 671.
https://doi.org/10.1182/blood.V114.22.671.671
Published: 2009
Journal Articles

A Novel Functional Assay Using Etoposide Plus Nutlin 3, FISH and Mutational Analysis Detects Heterogeneity of ATM/p53 Pathway Alterations in CLL.

Giles Best, PhD, Anne Gardiner, BSc, Rachel Ibbotson, PhD, Aneela Majid, PhD, Renata Walewska, MD, Belinda Austen, MD, Tanja Stankovic, PhD, Martin Dyer, MD, David Graham Oscier, MD
Journal: Blood
Blood (2006) 108 (11): 2795.
https://doi.org/10.1182/blood.V108.11.2795.2795
Published: 2006
Journal Articles

Defining the 10 Year Risk of Disease Progression in Stage A0 CLL.

Anne Gardiner, BSc, Zadie Davis, MSc, Parker Anton, BSc, Giles Best, PhD, Rachel Ibbotson, PhD, Sarah Mould, BSc, Sharron Glide, BSc, Peter Thomas, PhD, Jenny Orchard, MD, David Graham Oscier, MD
Journal: Blood
Blood (2006) 108 (11): 2772.
https://doi.org/10.1182/blood.V108.11.2772.2772
Published: 2006
Journal Articles

VH Gene Analysis in Splenic Marginal Zone Lymphoma Identifies Patients with Structurally Similar B Cell Receptors but Does Not Provide Prognostic Information.

David Graham Oscier, MD, Zadie Davis, MSc, Patricia Algara, MD, Alexandra Traverse-Glehen, MD, Kostos Stamatopoulos, MD, Jan Delabie, MD, Anne Gardiner, BSc, Chrysoula Belessi, MD, Nikolaos Loutaris, MD, Estella Matutes, MD, Gilles Salles, MD, Manuela Mollejo, MD, Miguel Piris, MD
Journal: Blood
Blood (2006) 108 (11): 2421.
https://doi.org/10.1182/blood.V108.11.2421.2421
Published: 2006